DNA Medicine Institute awarded Phase II NASA SBIR grant for developing nanoscale diagnostic technologies (News-Medical-Net)

DNA Medicine Institute, a commercial organization focused on advancing human health through innovation, today announced it has been awarded a Phase II Small Business Innovation Research (SBIR) contract from the National Aeronautics and Space Administration (NASA). The contract is designed to develop nanoscale diagnostic technologies that facilitate whole health analysis in a single drop of blood.
(read on…)

Related items

• NASA selects DNA Medicine Institute’s Nanoscale Diagnostics Technology for Phase II SBIR (PR Newswire via Yahoo! Finance)
• NASA selects DNA Medicine Institute’s Nanoscale Diagnostics Technology for Phase II SBIR (SpaceRef)
• Researchers developing nanoscale optical fibers to detect bioterrorist agents (PhysOrg)
• Blocking nuclear receptor may cut off tumor blood supply (PhysOrg)
• Carbon nanotube: A viable alternative for rapid DNA sequencing (News-Medical-Net)

Tags: business innovation research, contract, DNA, health, innovation, medicin, medicine, nano, nanos, national aeronautics and space, national aeronautics and space administration, national aeronautics and space administration nasa, small business innovation research

This entry was posted on Friday, January 29th, 2010 at 7:53 pm and is filed under News.